David Lowenschuss

David Lowenschuss is an experienced professional with a diverse work history in the legal, business, and healthcare sectors. David currently serves as the Chief Business Officer at Immusoft, a role they started in October 2022. Prior to this, they held the position of Chief Business Officer at Mekanistic Therapeutics, LLC from January 2017 to February 2023.

David also has a background in legal counsel, having worked as the Corporate Counsel at Pfizer from 2004 to 2008, Assistant General Counsel at Esperion Therapeutics from 2001 to 2004, and Corporate Counsel at The MEDSTAT Group, Inc. from 1995 to 1999.

In addition, David has entrepreneurial experience as the Founder, Chief Legal Officer, and Founding Board Member of Gemphire Therapeutics. David played a key role in raising private funding and taking the company public in August 2016.

Overall, David Lowenschuss has a well-rounded background and extensive experience in various leadership and legal roles within the healthcare and pharmaceutical industries.

David Lowenschuss attended the University of Michigan from 1986 to 1990. It is not specified whether they obtained a degree or the field of study. David then pursued a Master's degree in Transportation from the University of Michigan from 1990 to 1992. Finally, they attended The George Washington University Law School from 1992 to 1995 and earned their JD degree. No field of study is mentioned for their law degree.